LMCG Investments’s Puma Biotechnology PBYI Stock Holding History

LMCG Investments’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$6.36M	Buy	84,397 +41,256	+96%	+$3.9M	0.14%	275
2015 Q2	$5.04M	Buy	43,141 +6,089	+16%	+$1.1M	0.11%	298
2015 Q1	$8.75M	Buy	37,052 +31,274	+541%	+$6.69M	0.18%	227
2014 Q4	$1.09M	Buy	5,778 +455	+9%	+$101K	0.02%	383
2014 Q3	$1.27M	Sell	5,323 -14,138	-73%	-$2.9M	0.03%	374
2014 Q2	$1.28M	Buy	19,461 +7,582	+64%	+$539K	0.03%	371
2014 Q1	$1.24M	Sell	11,879 -4,209	-26%	-$495K	0.03%	371
2013 Q4	$1.67M	Buy	+16,088	New	+$944K	0.04%	345

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

LMCG Investments's PBYI Position: Q3 2015 in Review

LMCG Investments increased its Puma Biotechnology (PBYI) stake by 96% in Q3 2015, buying an estimated $3.9M and bringing the position to 84,397 shares worth $6.36M. The position accounts for 0.14% of the portfolio, ranked #275.

LMCG Investments first reported a position in PBYI in Q4 2013 and has held it in 8 quarters since. The position peaked at $8.75M in Q1 2015. 163 funds tracked by Wall St. Rank hold PBYI as of Q3 2015.

LMCG Investments held 84,397 shares of Puma Biotechnology worth $6.36M as of Q3 2015.
LMCG Investments bought 41,256 Puma Biotechnology shares in Q3 2015, an estimated $3.9M.
Puma Biotechnology made up 0.14% of LMCG Investments's portfolio in Q3 2015, its #275 holding.
LMCG Investments first reported a position in Puma Biotechnology in Q4 2013 and has held it in 8 quarters since.
LMCG Investments's Puma Biotechnology position peaked at $8.75M in Q1 2015.
163 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.